Protein A/Sbi cross-reactive human mAbs (Arsanis Biosciences)

N/A

Report date: 2025/03/20 10:07:48

Base Information

Drug NameProtein A/Sbi cross-reactive human mAbs (Arsanis Biosciences)
Drug Alias Namehuman mAb therapeutics (Arsanis Biosciences)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionImmunoglobulin inhibitors
TargetsImmunoglobulin
Therapy Area/IndicationsStaphylococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesX4 Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesX4 Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsStaphylococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A